Nolan Sean P. bought TSHA
January 12, 2026 · Form 4 insider transaction
Nolan Sean P. bought 1,008,000 shares of Taysha Gene Therapies, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,008,000
Price
$0.00
Total value
N/A
InsiderNolan Sean P.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after3,086,358
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.